Ornello, Raffaele http://orcid.org/0000-0001-9501-4031
Colangeli, Enrico http://orcid.org/0000-0002-8696-9407
Ceccanti, Giulia
Mammarella, Leondino
Desideri, Giovambattista http://orcid.org/0000-0002-0145-1271
Sacco, Simona http://orcid.org/0000-0003-0651-1939
Funding for this research was provided by:
Università degli Studi dell’Aquila
Article History
Received: 31 January 2023
Accepted: 20 February 2023
First Online: 28 February 2023
Declarations
:
: The study is part of a protocol approved by the Internal Review Board of the University of L’Aquila with registration number 13/2018.
: This study was performed in line with the principles of the Declaration of Helsinki.
: Informed consent was signed by patients or their authorized proxies.
: RO reports personal fees from Novartis, Teva, and Eli Lilly and non-financial support from Novartis and Teva, all unrelated to the submitted work. SS reports personal fees as a speaker or advisor from Abbott, Allergan-Abbvie, AstraZeneca, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, and Teva; research grants from Allergan, Novartis, and Uriach; non-financial support from Abbott, Allergan, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lilly, Lundbeck, Medtronic, Novartis, Pfizer, Starmed, and Teva; and fees for CME/education from Medscape and Neurodiem Ology Medical Education. All other authors declare no conflict of interest.